echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > US FDA approves Pfizer Prevnar 20: for adults ≥18 years of age

    US FDA approves Pfizer Prevnar 20: for adults ≥18 years of age

    • Last Update: 2021-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pfizer recently announced that the U.


    Prevnar 20 was approved through the priority review process


    It is worth mentioning that this is the first approval of a conjugate vaccine that can prevent most invasive pneumococcal diseases and pneumonia caused by 20 serotypes, of which 7 cause 40% of pneumococcal disease cases and deaths in the United States


    This approval is based on data from Pfizer’s adult clinical program, which includes phase 1 and phase 2 trials, and 3 phase 3 trials (NCT03760146, NCT03828617, NCT03835975), which evaluated the safety and immunogenicity of Prevnar 20 Sex


    Note: The original text has been deleted

    This article is from Bio Valley, for more information, please download the Bio Valley APP (http://

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.